New methods of monitoring residents' workloads could help alleviate overburdened schedules by pinpointing the busiest shifts, a new study shows.
Stanford research shows that having high blood pressure at peak exercise intensity could indicate good fitness, rather than revealing heart disease risk.
Entrepreneurs and scientists gathered at Stanford recently to discuss how to use scientific discoveries to launch startups and improve patient care.
Improved nutrition — and access to healthy foods — can reduce the effects of sleep deprivation in physicians, new Stanford Medicine ressearch suggests.
Physician burnout leads to higher job turnover rates and increased financial costs to institutions, Stanford researchers find.
A Stanford Medicine magazine article shares four stories of digital medicine helping patients.
Emergency surgery, compared to antibiotics, costs less and results in lower hospital readmission rates for appendicitis, a Stanford study finds.
Modifying diet and increasing exercise during midlife can help women ward off heart disease and diabetes, Stanford-led study finds.
The first nursing postdoc at Stanford, Nancy Dudley, brings a passion for the care of the severely ill to her palliative care research.
Stanford’s Peter Koltai is participating in an effort to advance much-needed ENT care for children in Zimbabwe.
The anti-inflammatory drug ketoprofen shows promise as effective medical treatment for lymphedema symptoms, small Stanford study finds
A new Stanford strategy for kidney transplant wait-list management has been shown to help patients get into surgery faster.
The taller you are the more likely you are to get varicose veins, according to Stanford study that researched the genetics of half a million people.
Stealth vaping fad fueled by JUUL, the most popular of the electronic cigarette devices, hooks teens on nicotine while hiding it from parents, teachers.
Snakebites decrease after periods of drought, according to a Stanford-led study that examined 20 years of snakebite data across California.
Ketamine, a promising new treatment for depression, works through the brain's opioid system, Stanford study finds, defying long held beliefs.
